艾迪药业：第三届董事会第五次会议决议公告

Core Viewpoint - The company announced the approval of several proposals, including adjustments to the 2025 stock option incentive plan, during the fifth meeting of the third board of directors [2] Group 1 - The company held its fifth meeting of the third board of directors on August 14 [2] - The board approved the proposal regarding adjustments to the 2025 stock option incentive plan [2]